Giovanni Manfredi Assanto
Giovanni Manfredi Assanto publishes mostly in Pathology and Forensic Medicine, Genetics and Hematology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Venous Thromboembolism Diagnosis and Management.
- World rank
- #4,594,534 of 7,710,434 ranked researchers
- Rank in Italy
- #155,358 of 242,206
- Works
- 62
- Citations
- 274
- Citations per work
- 4.4
What does Giovanni Manfredi Assanto research?
Giovanni Manfredi Assanto's work is mostly in Medicine (62%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3962.5%
- Medicine3962.5%
- Everything else2337.5%
- 1Pathology and Forensic Medicine18% of their works
- 2Genetics12% of their works
- 3Hematology10% of their works
- 4Oncology10% of their works
- 5Cardiology and Cardiovascular Medicine7% of their works
- 6Internal Medicine6% of their works
Research topics
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Venous Thromboembolism Diagnosis and Management
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Atrial Fibrillation Management and Outcomes
- Cancer Genomics and Diagnostics
Which keywords describe Giovanni Manfredi Assanto's research?
The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Prognostic Scoring System, Chronic Lymphocytic Leukemia, Genomic Aberrations, Antithrombotic Therapy and Venous Thromboembolism.
- Mutational Signatures
- Atrial Fibrillation
- Primary CNS Lymphoma
- Epstein-Barr Virus
- Myelofibrosis
- Venous Thromboembolism
- Genomic Aberrations
- Prognostic Scoring System
- Classification
- Rituximab
- Lymphoma
- Chronic Lymphocytic Leukemia
- Antithrombotic Therapy
- JAK2 Mutation
- Chemotherapy
- Kaposi's Sarcoma
- Anticoagulant Therapy
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Rituximab452 topics
- Classification311 topic
- Lymphoma311 topic
- Prognostic Scoring System152 topics
- Chronic Lymphocytic Leukemia141 topic
- Genomic Aberrations141 topic
- Antithrombotic Therapy101 topic
- Venous Thromboembolism101 topic
- JAK2 Mutation81 topic
- Myelofibrosis81 topic
- Chemotherapy71 topic
- Epstein-Barr Virus71 topic
- Kaposi's Sarcoma71 topic
- Primary CNS Lymphoma71 topic
- Anticoagulant Therapy61 topic
- Atrial Fibrillation61 topic
- Cancer Genomics41 topic
- Mutational Signatures41 topic
Where does Giovanni Manfredi Assanto work?
Giovanni Manfredi Assanto's main affiliation in the publication record is Sapienza University of Rome, Italy.
How many publications and citations does Giovanni Manfredi Assanto have?
OpenAlex counts 62 works and 274 citations for Giovanni Manfredi Assanto, an h-index of 9, ranking #4,594,534 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Giovanni Manfredi Assanto. Posts are plain text and can be reported.